MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.

[1]  A. Enk,et al.  Change in expression of MGMT during maturation of human monocytes into dendritic cells. , 2007, DNA repair.

[2]  Weiguo Lu,et al.  Amino acid substitution polymorphisms of the DNA repair gene MGMT and the susceptibility to cervical carcinoma. , 2007, Carcinogenesis.

[3]  E. Dogliotti,et al.  Base damage and single-strand break repair: mechanisms and functional significance of short- and long-patch repair subpathways. , 2007, DNA repair.

[4]  M. Weller,et al.  Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine , 2007, Oncogene.

[5]  M. Dolan,et al.  Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice. , 2006, Carcinogenesis.

[6]  B. Kaina,et al.  Human monocytes, but not dendritic cells derived from them, are defective in base excision repair and hypersensitive to methylating agents. , 2007, Cancer research.

[7]  B. Kaina,et al.  Local intracerebral administration of O6-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma , 2007, Journal of Neuro-Oncology.

[8]  F. Guengerich,et al.  Translesion Synthesis across O6-Alkylguanine DNA Adducts by Recombinant Human DNA Polymerases* , 2006, Journal of Biological Chemistry.

[9]  K. Srivenugopal,et al.  Chemopreventative strategies targeting the MGMT repair protein: augmented expression in human lymphocytes and tumor cells by ethanolic and aqueous extracts of several Indian medicinal plants. , 2006, International journal of oncology.

[10]  R. McLendon,et al.  Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma , 2006, Molecular Cancer Therapeutics.

[11]  C. Sommer,et al.  Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  B. Kaina,et al.  DNA damage-induced cell death by apoptosis. , 2006, Trends in molecular medicine.

[13]  B. Kaina,et al.  Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide. , 2006, Cancer letters.

[14]  Josef Jiricny,et al.  MutLα: At the Cutting Edge of Mismatch Repair , 2006, Cell.

[15]  P. Barber,et al.  Smoking is associated with a decrease of O6‐alkylguanine‐DNA alkyltransferase activity in bronchial epithelial cells , 2006, International journal of cancer.

[16]  D. Hunter,et al.  O6-Methylguanine-DNA Methyltransferase Leu84Phe and Ile143Val Polymorphisms and Risk of Colorectal Cancer in the Nurses’ Health Study and Physicians’ Health Study (United States) , 2006, Cancer Causes & Control.

[17]  M. Santibanez-Koref,et al.  Genetic Variation at the Human MGMT Locus and its Biological Consequences , 2006 .

[18]  P. Hsieh,et al.  ATR Kinase Activation Mediated by MutSα and MutLα in Response to Cytotoxic O6-Methylguanine Adducts , 2006 .

[19]  A. Bjørk,et al.  Repair deficient mice reveal mABH2 as the primary oxidative demethylase for repairing 1meA and 3meC lesions in DNA , 2006, The EMBO journal.

[20]  M. Weller,et al.  O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells , 2006, Journal of neurochemistry.

[21]  M. Christmann,et al.  Induction of DNA Repair Genes in Mammalian Cells in Response to Genotoxic Stress , 2006 .

[22]  C. Leonetti,et al.  Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide. , 2005, European journal of cancer.

[23]  T. Lindahl,et al.  Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase. , 2005, Cancer research.

[24]  S. Keir,et al.  Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft , 2005, Molecular Cancer Therapeutics.

[25]  E. Dogliotti,et al.  Base excision repair intermediates are mutagenic in mammalian cells , 2005, Nucleic acids research.

[26]  M. Jägerstad,et al.  Genotoxicity of heat-processed foods. , 2005, Mutation research.

[27]  David J. Chen,et al.  Two essential but distinct functions of the mammalian abasic endonuclease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Sribnick,et al.  Dexamethasone decreases temozolomide‐induced apoptosis in human gliobastoma T98G cells , 2005, Glia.

[29]  G. Dianov,et al.  Poly(ADP‐ribose) polymerase‐1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts , 2005, The FEBS journal.

[30]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[31]  B. Demple,et al.  A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. , 2005, Molecular cell.

[32]  A. Pegg,et al.  Beta-glucuronidase-cleavable prodrugs of O6-benzylguanine and O6-benzyl-2'-deoxyguanosine. , 2005, Journal of medicinal chemistry.

[33]  M. Crescenzi,et al.  The accumulation of MMS-induced single strand breaks in G1 phase is recombinogenic in DNA polymerase β defective mammalian cells , 2005, Nucleic acids research.

[34]  L. Anderson,et al.  Intra- and intercellular variations in the repair efficiency of O6-methylguanine, and their contribution to kinetic complexity. , 2004, Mutation research.

[35]  M. Christmann,et al.  Inhibition of O6-Methylguanine-DNA Methyltransferase by Glucose-Conjugated Inhibitors: Comparison with Nonconjugated Inhibitors and Effect on Fotemustine and Temozolomide-Induced Cell Death , 2004, Journal of Pharmacology and Experimental Therapeutics.

[36]  D. DeMarini.  Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. , 2004, Mutation research.

[37]  T. Shiraishi,et al.  Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. , 2004, Journal of neurosurgery.

[38]  Susan M. Chang,et al.  Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. , 2004, International journal of radiation oncology, biology, physics.

[39]  M. Ranson,et al.  Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase. , 2004, Molecular cancer therapeutics.

[40]  T. Lindahl,et al.  Demethylation of 3-Methylthymine in DNA by Bacterial and Human DNA Dioxygenases* , 2004, Journal of Biological Chemistry.

[41]  J. Raizer,et al.  Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy. , 2004, Neuro-oncology.

[42]  K. Rich,et al.  BCNU Down-Regulates Anti-Apoptotic Proteins Bcl-xL and Bcl-2 in Association with Cell Death in Oligodendroglioma-Derived Cells , 2004, Journal of Neuro-Oncology.

[43]  A. Pegg,et al.  2-amino-O4-benzylpteridine derivatives: potent inactivators of O6-alkylguanine-DNA alkyltransferase. , 2004, Journal of medicinal chemistry.

[44]  K. Tanaka,et al.  Role of nucleotide- and base-excision repair in genotoxin-induced neuronal cell death. , 2004, DNA repair.

[45]  Lili Liu,et al.  Therapeutic impact of methoxyamine: blocking repair of abasic sites in the base excision repair pathway. , 2004, Current opinion in investigational drugs.

[46]  R. Stupp,et al.  Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients , 2004, Clinical Cancer Research.

[47]  B. Kaina,et al.  Mechanisms and consequences of methylating agent-induced SCEs and chromosomal aberrations: a long road traveled and still a far way to go , 2004, Cytogenetic and Genome Research.

[48]  G. Dianov,et al.  XRCC1-DNA polymerase beta interaction is required for efficient base excision repair. , 2004, Nucleic acids research.

[49]  B. Kaina,et al.  Loss of ATM sensitizes against O6-methylguanine triggered apoptosis, SCEs and chromosomal aberrations. , 2004, DNA repair.

[50]  S. Gerson.  MGMT: its role in cancer aetiology and cancer therapeutics , 2004, Nature Reviews Cancer.

[51]  Luca Regli,et al.  Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide , 2004, Clinical Cancer Research.

[52]  M. Ranson,et al.  Dual repair modulation reverses Temozolomide resistance in vitro. , 2004, Molecular cancer therapeutics.

[53]  B. Kaina,et al.  Apoptosis triggered by DNA damage O6-methylguanine in human lymphocytes requires DNA replication and is mediated by p53 and Fas/CD95/Apo-1 , 2004, Oncogene.

[54]  G. Broggi,et al.  Phase II Trial of Cisplatin Plus Temozolomide, in Recurrent and Progressive Malignant Glioma Patients , 2004, Journal of Neuro-Oncology.

[55]  E. Seeberg,et al.  Substrate specificities of bacterial and human AlkB proteins. , 2004, Nucleic acids research.

[56]  Leah E. Mechanic,et al.  The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. , 2003, The Journal of clinical investigation.

[57]  Ni Ai,et al.  Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. , 2003, Cancer research.

[58]  B. Kaina,et al.  Apoptosis induced by MNNG in human TK6 lymphoblastoid cells is p53 and Fas/CD95/Apo-1 related. , 2003, Mutation research.

[59]  J. Winum,et al.  Cytotoxicity, DNA Damage, and Apoptosis Induced by New Fotemustine Analogs on Human Melanoma Cells in Relation to O6-Methylguanine DNA-Methyltransferase Expression , 2003, Journal of Pharmacology and Experimental Therapeutics.

[60]  Samuel H. Wilson,et al.  Base Excision Repair Intermediates Induce p53-independent Cytotoxic and Genotoxic Responses* , 2003, Journal of Biological Chemistry.

[61]  M. Sekiguchi,et al.  Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis. , 2003, DNA repair.

[62]  M. Santibanez-Koref,et al.  The alleles of the DNA repair gene O6-alkylguanine-DNA alkyltransferase are expressed at different levels in normal human lung tissue. , 2003, Carcinogenesis.

[63]  Hyeon Joo Lee,et al.  Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. , 2003, The American journal of pathology.

[64]  K. Caldecott.  XRCC1 and DNA strand break repair. , 2003, DNA repair.

[65]  K. Bhakat,et al.  CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. , 2003, Carcinogenesis.

[66]  G. Margison,et al.  O6-alkylguanine-DNA alkyltransferase inactivation in cancer chemotherapy. , 2003, Mini reviews in medicinal chemistry.

[67]  G. Margison,et al.  Variability and regulation of O6-alkylguanine-DNA alkyltransferase. , 2003, Carcinogenesis.

[68]  B. Kaina,et al.  DNA repair protein MGMT protects against N-methyl-N-nitrosourea-induced conversion of benign into malignant tumors. , 2003, Carcinogenesis.

[69]  Magnar Bjørås,et al.  Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA , 2003, Nature.

[70]  T. Bessho.  Induction of DNA Replication-mediated Double Strand Breaks by Psoralen DNA Interstrand Cross-links* , 2003, The Journal of Biological Chemistry.

[71]  J. Jiricny,et al.  The Effect of O 6-Alkylguanine-DNA Alkyltransferase and Mismatch Repair Activities on the Sensitivity of Human Melanoma Cells to Temozolomide, 1,3-bis(2-Chloroethyl)1-nitrosourea, and Cisplatin , 2003, Journal of Pharmacology and Experimental Therapeutics.

[72]  R. Schulte‐Hermann,et al.  Coffee and its chemopreventive components Kahweol and Cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver--comparison with phase II xenobiotic metabolism. , 2003, Mutation research.

[73]  P. Bates,et al.  Reversal of DNA alkylation damage by two human dioxygenases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[74]  A. Bolzán,et al.  Genotoxicity of streptozotocin. , 2002, Mutation research.

[75]  A. Lehmann.  Replication of damaged DNA in mammalian cells: new solutions to an old problem. , 2002, Mutation research.

[76]  G. Margison,et al.  Heterogeneity of O6-Alkylguanine-DNA Alkyltransferase Activity in Colorectal Cancer: Implications for Treatment , 2002, Oncology.

[77]  J. Madelmont,et al.  Inhibition of O6-alkylguanine-DNA alkyltransferase by O6-benzyl-N 2-acetylguanosine increases chloroethylnitrosourea-induced apoptosis in Mer+ human melanoma cells , 2002, Melanoma research.

[78]  M. Christmann,et al.  DNA repair in resistance to alkylating anticancer drugs. , 2002, International journal of clinical pharmacology and therapeutics.

[79]  H. Koyama,et al.  Vertebrate cells lacking FEN-1 endonuclease are viable but hypersensitive to methylating agents and H2O2. , 2002, Nucleic acids research.

[80]  D. Bigner,et al.  Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcoma. , 2002, Molecular cancer therapeutics.

[81]  A. Pegg,et al.  Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide. , 2002, Cancer research.

[82]  M. Christmann,et al.  Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activity. , 2002, Nucleic acids research.

[83]  A. Pegg,et al.  Degradation of the alkylated form of the DNA repair protein, O(6)-alkylguanine-DNA alkyltransferase. , 2002, Carcinogenesis.

[84]  Paul Modrich,et al.  Human Exonuclease I Is Required for 5′ and 3′ Mismatch Repair* , 2002, The Journal of Biological Chemistry.

[85]  B. Kaina,et al.  Deficiency in DNA polymerase beta provokes replication-dependent apoptosis via DNA breakage, Bcl-2 decline and caspase-3/9 activation. , 2002, Cancer research.

[86]  M. Santibanez-Koref,et al.  O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[87]  B. Kaina,et al.  Repair of O(6)-methylguanine is not affected by thymine base pairing and the presence of MMR proteins. , 2001, Mutation research.

[88]  J. Minna,et al.  DNA methylation profiles of lung tumors. , 2001, Molecular cancer therapeutics.

[89]  P. Gais,et al.  Cell type-specific induction of O6-alkylguanine-DNA alkyltransferase mRNA expression in rat liver during regeneration, inflammation and preneoplasia , 2001, Journal of Cancer Research and Clinical Oncology.

[90]  K. Bjornson,et al.  Distinct MutS DNA-binding Modes That Are Differentially Modulated by ATP Binding and Hydrolysis* , 2001, The Journal of Biological Chemistry.

[91]  R. Kanaar,et al.  Repair of DNA interstrand cross-links. , 2001, Mutation research.

[92]  Samuel H. Wilson,et al.  DNA Polymerase (cid:1) -mediated Long Patch Base Excision Repair POLY(ADP-RIBOSE) POLYMERASE-1 STIMULATES STRAND DISPLACEMENT DNA SYNTHESIS* , 2022 .

[93]  F. Oesch,et al.  Long-time expression of DNA repair enzymes MGMT and APE in human peripheral blood mononuclear cells , 2001, Archives of Toxicology.

[94]  D. Wilson,et al.  The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. , 2001, Mutation research.

[95]  D. Schadendorf,et al.  Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene mgmt , 2001, International journal of cancer.

[96]  B. Kaina,et al.  DNA double-strand breaks trigger apoptosis in p53-deficient fibroblasts. , 2001, Carcinogenesis.

[97]  M. Christmann,et al.  Nuclear Translocation of Mismatch Repair Proteins MSH2 and MSH6 as a Response of Cells to Alkylating Agents* , 2000, The Journal of Biological Chemistry.

[98]  Scar,et al.  Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.

[99]  M. Grompe,et al.  DNA Replication Is Required To Elicit Cellular Responses to Psoralen-Induced DNA Interstrand Cross-Links , 2000, Molecular and Cellular Biology.

[100]  P. McHugh,et al.  Defining the Roles of Nucleotide Excision Repair and Recombination in the Repair of DNA Interstrand Cross-Links in Mammalian Cells , 2000, Molecular and Cellular Biology.

[101]  B. Kaina,et al.  Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. , 2000, Cancer research.

[102]  K. Srivenugopal,et al.  DNA repair protein O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells. , 2000, The Biochemical journal.

[103]  Samuel H. Wilson,et al.  The lyase activity of the DNA repair protein β-polymerase protects from DNA-damage-induced cytotoxicity , 2000, Nature.

[104]  V. Schreiber,et al.  Base excision repair is impaired in mammalian cells lacking Poly(ADP-ribose) polymerase-1. , 2000, Biochemistry.

[105]  A. Pegg.  Repair of O6-alkylguanine by alkyltransferases , 2000 .

[106]  K. Srivenugopal,et al.  Protein phosphorylation is a regulatory mechanism for O6-alkylguanine-DNA alkyltransferase in human brain tumor cells. , 2000, Cancer research.

[107]  Josef Jiricny,et al.  Mediating mismatch repair , 2000, Nature Genetics.

[108]  M. J. Hickman,et al.  Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[109]  J. Reid,et al.  Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[110]  L. Panasci,et al.  Relationship Between O6-methylguanine-DNA Methyltransferase Levels and Clinical Response Induced by Chloroethylnitrosourea Therapy in Glioma Patients , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[111]  James Allan,et al.  DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. , 1999, Mutagenesis.

[112]  Samuel H. Wilson,et al.  Cells deficient in DNA polymerase beta are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakage. , 1999, Cancer research.

[113]  M. Berger,et al.  O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[114]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.

[115]  J. Griffith,et al.  hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA. , 1999, Molecular cell.

[116]  C. Ramana,et al.  Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone , 1999, Oncogene.

[117]  G. Rustin,et al.  O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. , 1998, British Journal of Cancer.

[118]  H. Eyre,et al.  Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[119]  D. Cooper,et al.  Alkylpurine–DNA–N-Glycosylase Knockout Mice Show Increased Susceptibility to Induction of Mutations by Methyl Methanesulfonate , 1998, Molecular and Cellular Biology.

[120]  L. Samson,et al.  Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents. , 1998, Cancer research.

[121]  C. Ramana,et al.  Regulation of expression of the DNA repair gene O6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling. , 1998, Cancer research.

[122]  S. H. Wilson,et al.  Mammalian base excision repair by DNA polymerases δ and ε , 1998, Oncogene.

[123]  B. Kaina,et al.  p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents , 1998, Oncogene.

[124]  B. Kaina.  Critical steps in alkylation-induced aberration formation. , 1998, Mutation research.

[125]  J. Ménissier-de murcia,et al.  DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines. , 1998, Nucleic acids research.

[126]  M. Christmann,et al.  Mismatch G-T binding activity and MSH2 expression is quantitatively related to sensitivity of cells to methylating agents. , 1998, Carcinogenesis.

[127]  H. Vrieling,et al.  Methyl methanesulfonate-induced hprt mutation spectra in the Chinese hamster cell line CHO9 and its xrcc1-deficient derivative EM-C11. , 1998, Mutation research.

[128]  J. Engelbergs,et al.  Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[129]  L. Samson,et al.  O6-alkylguanine DNA lesions trigger apoptosis. , 1998, Carcinogenesis.

[130]  B. Kaina,et al.  Chromosomal instability, reproductive cell death and apoptosis induced by O6-methylguanine in Mex-, Mex+ and methylation-tolerant mismatch repair compromised cells: facts and models. , 1997, Mutation research.

[131]  L. Samson,et al.  Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[132]  B. Kaina,et al.  The DNA repair protein O6-methylguanine-DNA methyltransferase protects against skin tumor formation induced by antineoplastic chloroethylnitrosourea. , 1997, Cancer research.

[133]  T. Iwakuma,et al.  High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. , 1997, Carcinogenesis.

[134]  T. Lindahl,et al.  Second pathway for completion of human DNA base excision‐repair: reconstitution with purified proteins and requirement for DNase IV (FEN1) , 1997, The EMBO journal.

[135]  T. Tsuzuki,et al.  Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting. , 1997, Carcinogenesis.

[136]  Paul Modrich,et al.  DNA Polymerase (cid:100) Is Required for Human Mismatch Repair in Vitro * , 2022 .

[137]  M. Armstrong,et al.  Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents. , 1997, Mutation research.

[138]  B. Kaina,et al.  Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes. , 1996, Carcinogenesis.

[139]  K. Caldecott,et al.  XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. , 1996, Nucleic acids research.

[140]  M. Kastan,et al.  Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU. , 1996, Blood.

[141]  B. F. Li,et al.  The nuclear targeting and nuclear retention properties of a human DNA repair protein O6‐methylguanine‐DNA methyltransferase are both required for its nuclear localization: the possible implications. , 1996, The EMBO journal.

[142]  B. Kaina,et al.  Targeted expression of human O(6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis. , 1996, Cancer research.

[143]  G. Ojemann,et al.  Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[144]  D. Lilley,et al.  Human MutScv recognizes damaged DNA base pairs containing 06-methylguanine, 04-methylthymine, or the cisplatin-d(GpG) adduct , 2005 .

[145]  T. Iwakuma,et al.  Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. , 1996, Carcinogenesis.

[146]  T. Kunkel,et al.  DNA-replication fidelity, mismatch repair and genome instability in cancer cells. , 1996, European journal of biochemistry.

[147]  M. Prados,et al.  Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. , 1996, Cancer research.

[148]  B. Kaina,et al.  Protective effect of O6‐methylguanine‐DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs , 1996, International journal of cancer.

[149]  L. Samson,et al.  Repair‐deficient 3‐methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation‐induced chromosome damage and cell killing. , 1996, The EMBO journal.

[150]  A. Clarke,et al.  Induction of murine O6-alkylguanine-DNA-alkyltransferase in response to ionising radiation is p53 gene dose dependent. , 1996, Oncogene.

[151]  K. Srivenugopal,et al.  Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea. , 1996, Biochemistry.

[152]  Samuel H. Wilson,et al.  Requirement of mammalian DNA polymerase-β in base-excision repair , 1996, Nature.

[153]  S. Haas,et al.  Activity of the DNA repair protein O6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue. , 1996, Cancer detection and prevention.

[154]  P. Modrich,et al.  Mismatch repair in replication fidelity, genetic recombination, and cancer biology. , 1996, Annual review of biochemistry.

[155]  J. Jiricny,et al.  GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. , 1995, Science.

[156]  T. Brent,et al.  Localization of methylation sites in the human O6-methylguanine-DNA methyltransferase promoter: correlation with gene suppression. , 1995, Carcinogenesis.

[157]  S. Haas,et al.  O6‐methylguanine‐DNA methyltransferase activity in breast and brain tumors , 1995, International journal of cancer.

[158]  S. K. Greenwood,et al.  A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells. , 1995, Mutation research.

[159]  P. Modrich,et al.  Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[160]  T. P. Pretlow,et al.  Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. , 1995, Carcinogenesis.

[161]  B. Kaina,et al.  Constitutive expression and inducibility of O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in rat liver cells exhibiting different status of differentiation. , 1995, Biochimica et biophysica acta.

[162]  B. Kaina,et al.  Overexpression of N-methylpurine-DNA glycosylase in Chinese hamster ovary cells renders them more sensitive to the production of chromosomal aberrations by methylating agents--a case of imbalanced DNA repair. , 1995, Mutation research.

[163]  P. Karran,et al.  DNA damage tolerance, mismatch repair and genome instability , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[164]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[165]  J. Costello,et al.  Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. , 1994, The Journal of biological chemistry.

[166]  S. Seeber,et al.  Repair of O6-alkylguanines in the nuclear DNA of human lymphocytes and leukaemic cells: analysis at the single-cell level. , 1994, British Journal of Cancer.

[167]  R. Fleischmann,et al.  Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.

[168]  R. Mirzayans,et al.  On the quantitative relationship between O6-methylguanine residues in genomic DNA and production of sister-chromatid exchanges, mutations and lethal events in a Mer- human tumor cell line. , 1994, Mutation research.

[169]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[170]  T. O'Connor,et al.  Purification and characterization of human 3-methyladenine-DNA glycosylase. , 1993, Nucleic acids research.

[171]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[172]  C. Beattie,et al.  Estrous cycle modulation of O6-alkylguanine-DNA alkyltransferase expression in rat mammary epithelial cells. , 1993, Cancer letters.

[173]  L. Marnett,et al.  Endogenous DNA adducts: potential and paradox. , 1993, Chemical research in toxicology.

[174]  T. Ishikawa,et al.  O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[175]  G. Aquilina,et al.  Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage , 1993, Nature.

[176]  S. Gerson,et al.  The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. , 1993, Science.

[177]  B. Kaina,et al.  Contribution of O6‐alkylguanine and N‐alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: New insights gained from studies of genetically engineered mammalian cell lines , 1993, Environmental and molecular mutagenesis.

[178]  M. Citron,et al.  O6-methylguanine-DNA methyltransferase in human normal and malignant lung tissues. , 1993, Cancer investigation.

[179]  P. E. Gonzaga,et al.  Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA. , 1992, Cancer research.

[180]  B. Kaina,et al.  Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. , 1992, Carcinogenesis.

[181]  H. Krokan,et al.  Expression of O6-methylguanine--DNA methyltransferase and uracil--DNA glycosylase in human placentae from smokers and non-smokers. , 1992, Carcinogenesis.

[182]  T. Skopek,et al.  Modulation of ethylnitrosourea-induced toxicity and mutagenicity in human cells by O6-benzylguanine. , 1992, Cancer research.

[183]  G. Poli,et al.  In vitro and in vivo evidence for the formation of methyl radical from procarbazine: a spin-trapping study. , 1992, Carcinogenesis.

[184]  B. Kaina,et al.  Genomic differences between O6-methylguanine-DNA methyltransferase proficient (Mex+) and deficient (Mex-) cell lines: possible role of genetic and epigenetic changes in conversion of Mex+ into Mex-. , 1992, Biochemical and biophysical research communications.

[185]  M. Ikenaga,et al.  O6-methylguanine-DNA methyltransferase activity in human tumors. , 1992, Carcinogenesis.

[186]  B. Kaina,et al.  Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. , 1991, Carcinogenesis.

[187]  B. Kaina,et al.  Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments , 1991, Molecular and cellular biology.

[188]  S. Mitra,et al.  Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glycosylase. , 1991, The Journal of biological chemistry.

[189]  Y. Yamaoka,et al.  O6-methylguanine-DNA methyltransferase activity in human liver tumors. , 1991, Carcinogenesis.

[190]  A. Pegg.  Properties of mammalian O6-alkylguanine-DNA transferases. , 1990, Mutation research.

[191]  P. Swann,et al.  Why do O6-alkylguanine and O4-alkylthymine miscode? The relationship between the structure of DNA containing O6-alkylguanine and O4-alkylthymine and the mutagenic properties of these bases. , 1990, Mutation research.

[192]  D. Beranek.  Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. , 1990, Mutation research.

[193]  B. Kaina,et al.  DNA repair and chromosomal stability in the alkylating agent-hypersensitive Chinese hamster cell line 27-1. , 1990, Mutation research.

[194]  G. Margison,et al.  Expression of an E.coli O6-alkylguanine DNA alkyltransferase gene in Chinese hamster cells protects against N-methyl and N-ethylnitrosourea induced reverse mutation at the hypoxanthine phosphoribosyl transferase locus. , 1988, Mutagenesis.

[195]  G. Margison,et al.  Increased O6-alkylguanine alkyltransferase activity in Chinese hamster V79 cells following selection with chloroethylating agents. , 1988, Carcinogenesis.

[196]  G. Margison,et al.  Protection of Chinese hamster cells against the cytotoxic and mutagenic effects of alkylating agents by transfection of the Escherichia coli alkyltransferase gene and a truncated derivative. , 1987, Mutagenesis.

[197]  P. O'connor,et al.  Selective repair of methylated purines in regions of chromatin DNA. , 1986, Carcinogenesis.

[198]  N. Berger,et al.  Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. , 1986, Carcinogenesis.

[199]  P. Magee,et al.  Studies on the distribution of O6-methylguanine-DNA methyltransferase in rat. , 1986, Biochemical pharmacology.

[200]  B. Kaina,et al.  Dependency of the yield of sister-chromatid exchanges induced by alkylating agents on fixation time. Possible involvement of secondary lesions in sister-chromatid exchange induction. , 1985, Mutation research.

[201]  B. Kaina.  The interrelationship between SCE induction, cell survival, mutagenesis, aberration formation and DNA synthesis inhibition in V79 cells treated with N-methyl-N-nitrosourea or N-methyl-N'-nitro-N-nitrosoguanidine. , 1985, Mutation research.

[202]  R Montesano,et al.  Relevance of nitrosamines to human cancer. , 1984, Carcinogenesis.

[203]  C. Harris,et al.  O6-alkylguanine-DNA alkyltransferase activity in normal human tissues and cells. , 1984, Cancer research.

[204]  M. D. Topal,et al.  Mechanisms of chemical mutagenesis and carcinogenesis: effects on DNA replication of methylation at the O6-guanine position of dGTP. , 1983, Carcinogenesis.

[205]  M. James,et al.  A biochemical defect in the repair of alkylated DNA in cells from an immunodeficient patient (46BR). , 1983, Carcinogenesis.

[206]  R. S. Foote,et al.  Repair of O6-methylguanine in DNA by demethylation is lacking in Mer- human tumor cell strains. , 1983, Carcinogenesis.

[207]  W. Tong,et al.  Formation of the cross-link 1-[N3-deoxycytidyl),2-[N1-deoxyguanosinyl]ethane in DNA treated with N,N'-bis(2-chloroethyl)-N-nitrosourea. , 1982, Cancer research.

[208]  I. Zagon,et al.  Nucleic acids and protein in brains and cerebella of rats transplacentally exposed to ethylnitrosourea , 1981, Brain Research Bulletin.

[209]  D. Scudiero,et al.  Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains , 1980, Nature.

[210]  R. Goth-Goldstein.  Inability of Chinese hamster ovary cells to excise O6-alkylguanine. , 1980, Cancer research.

[211]  D. Scudiero,et al.  Human tumor cell strains defective in the repair of alkylation damage. , 1980, Carcinogenesis.

[212]  R. Saffhill,et al.  DNA synthesis with methylated poly(dC-dG) templates. Evidence for a competitive nature to miscoding by O(6)-methylguanine. , 1979, Biochimica et biophysica acta.

[213]  D. Bootsma,et al.  Induction of sister chromatid exchanges in xeroderma pigmentosum cells after exposure to ultraviolet light. , 1977, Mutation research.

[214]  L. Samson,et al.  A new pathway for DNA repair in Escherichia coli , 1977, Nature.

[215]  T. Lindahl.  New class of enzymes acting on damaged DNA , 1976, Nature.

[216]  P. Kleihues,et al.  Chemical carcinogenesis in the nervous system. Preferential accumulation of O6-methylguanine in rat brain deoxyribonucleic acid during repetitive administration of N-methyl-N-nitrosourea. , 1975, The Biochemical journal.

[217]  M. Rajewsky,et al.  Persistence of O6-ethylguanine in rat-brain DNA: correlation with nervous system-specific carcinogenesis by ethylnitrosourea. , 1974, Proceedings of the National Academy of Sciences of the United States of America.